ANVS

Annovis Bio

-$5.2M

Net Activity

Institutions Holding

58

Popularity Rank

#5622

Avg Weight

0.00%

Total Value

$11.7M

Ownership Trend

58 institutions currently hold ANVS, with 24 net buyers and 20 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

20

Net Buying Institutions

24

Key Holders

View all 58 holding institutions

Quarterly Activity

Recent Activity

+$6.6M

Total Buy Value

$5.7M

Total Sell Value

New buy10
Trim12
Add14
Sold out8

24

Net Buyers

20

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-07-10

View all Form 8-K filings

FAQ

Who are the top institutional investors holding ANNOVIS BIO (ANVS)?
Major stakeholders currently include Marshall Wace, LLP ($2.6M), Vanguard Capital Management LLC ($1.9M), Two Sigma Investments, LP ($1.4M). Based on the latest 13F filings, there are a total of 58 tracked investment funds and institutions maintaining positions in ANVS.
What is the overall institutional sentiment toward ANVS recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $5.2M, driven by 24 managers accumulating shares while 20 reduced their exposure.
Which institutions have been selling or reducing their ANVS positions?
In the latest period, 12 funds trimmed their holdings, and 8 managers completely exited their positions. The aggregate reported sell value was $5.7M.
Are there any notable investors adding ANVS to their portfolios?
Yes, buying activity remains notable. 10 institutions opened new positions in {ticker}, and 14 existing holders added to their shares. The total reported buy value for the quarter amounted to $6.6M.

Related Stocks